ENIGMA and global neuroscience: A decade of large-scale studies of the brain in health and disease across more than 40 countries.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
20 03 2020
Historique:
received: 03 07 2019
accepted: 20 12 2019
revised: 11 12 2019
entrez: 22 3 2020
pubmed: 22 3 2020
medline: 22 6 2021
Statut: epublish

Résumé

This review summarizes the last decade of work by the ENIGMA (Enhancing NeuroImaging Genetics through Meta Analysis) Consortium, a global alliance of over 1400 scientists across 43 countries, studying the human brain in health and disease. Building on large-scale genetic studies that discovered the first robustly replicated genetic loci associated with brain metrics, ENIGMA has diversified into over 50 working groups (WGs), pooling worldwide data and expertise to answer fundamental questions in neuroscience, psychiatry, neurology, and genetics. Most ENIGMA WGs focus on specific psychiatric and neurological conditions, other WGs study normal variation due to sex and gender differences, or development and aging; still other WGs develop methodological pipelines and tools to facilitate harmonized analyses of "big data" (i.e., genetic and epigenetic data, multimodal MRI, and electroencephalography data). These international efforts have yielded the largest neuroimaging studies to date in schizophrenia, bipolar disorder, major depressive disorder, post-traumatic stress disorder, substance use disorders, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, autism spectrum disorders, epilepsy, and 22q11.2 deletion syndrome. More recent ENIGMA WGs have formed to study anxiety disorders, suicidal thoughts and behavior, sleep and insomnia, eating disorders, irritability, brain injury, antisocial personality and conduct disorder, and dissociative identity disorder. Here, we summarize the first decade of ENIGMA's activities and ongoing projects, and describe the successes and challenges encountered along the way. We highlight the advantages of collaborative large-scale coordinated data analyses for testing reproducibility and robustness of findings, offering the opportunity to identify brain systems involved in clinical syndromes across diverse samples and associated genetic, environmental, demographic, cognitive, and psychosocial factors.

Identifiants

pubmed: 32198361
doi: 10.1038/s41398-020-0705-1
pii: 10.1038/s41398-020-0705-1
pmc: PMC7083923
doi:

Types de publication

Journal Article Meta-Analysis Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

100

Subventions

Organisme : NIBIB NIH HHS
ID : R01 EB015611
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG058507
Pays : United States
Organisme : Medical Research Council
ID : MR/L016311/1
Pays : United Kingdom
Organisme : NIDA NIH HHS
ID : R01 DA047119
Pays : United States
Organisme : NIH HHS
ID : S10 OD023696
Pays : United States
Organisme : MRF
ID : MRF_MRF-058-0009-RG-DESR-C0759
Pays : United Kingdom
Organisme : NINDS NIH HHS
ID : R21 NS107739
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS115845
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States
Organisme : MRF
ID : MRF_MRF-058-0004-RG-DESRI
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R21 MH116473
Pays : United States
Organisme : NICHD NIH HHS
ID : K01 HD091283
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH085953
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH111671
Pays : United States
Organisme : ODCDC CDC HHS
ID : S10 OD023696
Pays : United States
Organisme : Medical Research Council
ID : MR/R00465X/1
Pays : United Kingdom
Organisme : NIMH NIH HHS
ID : R01 MH116147
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH117601
Pays : United States
Organisme : NIMH NIH HHS
ID : U01 MH108148
Pays : United States
Organisme : NIBIB NIH HHS
ID : U54 EB020403
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG059874
Pays : United States
Organisme : NIA NIH HHS
ID : R56 AG058854
Pays : United States
Organisme : NINDS NIH HHS
ID : R01 NS110347
Pays : United States
Organisme : Medical Research Council
ID : MR/S020306/1
Pays : United Kingdom

Références

van Erp, T. G. M. et al. Cortical Brain Abnormalities in 4474 Individuals with Schizophrenia and 5098 Control Subjects via the Enhancing Neuro Imaging Genetics through Meta Analysis (ENIGMA) Consortium. Biol. Psychiatry 84, 644–654 (2018).
pubmed: 29960671 pmcid: 6177304
Hibar, D. P. et al. Cortical abnormalities in bipolar disorder: an MRI analysis of 6503 individuals from the ENIGMA Bipolar Disorder Working Group. Mol. Psychiatry 23, 932–942 (2018).
pubmed: 28461699
Schmaal, L. et al. Cortical abnormalities in adults and adolescents with major depression based on brain scans from 20 cohorts worldwide in the ENIGMA major depressive disorder working group. Mol. Psychiatry 22, 900–909 (2017).
pubmed: 27137745
Logue, M. W. et al. Smaller hippocampal volume in posttraumatic stress disorder: a multisite ENIGMA-PGC study: subcortical volumetry results from posttraumatic stress disorder consortia. Biol. Psychiatry 83, 244–253 (2018).
pubmed: 29217296
Mackey, S. et al. Mega-analysis of gray matter volume in substance dependence: general and substance-specific regional effects. Am. J. Psychiatry 176, 119–128 (2019).
pubmed: 30336705
Boedhoe, P. S. W. et al. Cortical abnormalities associated with pediatric and adult obsessive-compulsive disorder: findings from the ENIGMA obsessive-compulsive disorder working group. Am. J. Psychiatry 175, 453–462 (2018).
pubmed: 29377733
Hoogman, M. et al. Brain imaging of the cortex in ADHD: a coordinated analysis of large-scale clinical and population-based samples. Am. J. Psychiatry. https://doi.org/10.1176/appi.ajp.2019.18091033 (2019).
doi: 10.1176/appi.ajp.2019.18091033 pubmed: 31014101 pmcid: 6879185
van Rooij, D. et al. Cortical and subcortical brain morphometry differences between patients with autism spectrum disorder and healthy individuals across the lifespan: results from the ENIGMA ASD Working Group. Am. J. Psychiatry 175, 359–369 (2018).
pubmed: 29145754
Whelan, C. D. et al. Structural brain abnormalities in the common epilepsies assessed in a worldwide ENIGMA study. Brain 141, 391–408 (2018).
pubmed: 29365066 pmcid: 5837616
Sun, D. et al. Large-scale mapping of cortical alterations in 22q11.2 deletion syndrome: convergence with idiopathic psychosis and effects of deletion size. Mol. Psychiatry https://doi.org/10.1038/s41380-018-0078-5 (2018).
doi: 10.1038/s41380-018-0078-5 pubmed: 30120420 pmcid: 6378130
de Zwarte, S. M. C. et al. The association between familial risk and brain abnormalities is disease-specific: an ENIGMA–relatives study of schizophrenia and bipolar disorder. Biol. Psychiatry 86, 545–556 (2019).
pubmed: 31443932 pmcid: 7068800
Boedhoe, P. et al. Subcortical brain volume, regional cortical thickness and surface area variations across attention-deficit/hyperactivity disorder (ADHD), autism spectrum disorder (ASD), and obsessive-compulsive disorder (OCD). Am. J. Psychiatry (2019) (submitted revision). Preprint at https://www.biorxiv.org/content/10.1101/673012v1 .
Grasby, K. L. et al. The genetic architecture of the human cerebral cortex. Science. (2020) (in press). Preprint at https://doi.org/10.1101/399402 .
Satizabal, C. L. et al. Genetic architecture of subcortical brain structures in 38,854 individuals worldwide. Nat. Genet 51, 1624–1636 (2019).
pubmed: 31636452 pmcid: 7055269
Hofer, E. et al. Genetic determinants of cortical structure (thickness, surface area and volumes) among disease free adults in the CHARGE Consortium. bioRxiv. https://doi.org/10.1101/409649 (2019).
doi: 10.1101/409649
Shin, J. et al. Planar cell polarity pathway and development of the human visual cortex. bioRxiv. https://doi.org/10.1101/404558 (2018).
doi: 10.1101/404558
Villalón-Reina, J. E. et al. Altered white matter microstructure in 22q11.2 deletion syndrome: A multi-site diffusion tensor imaging study. Mol. Psychiatry. https://doi.org/10.1038/s41380-019-0450-0 (2019).
Kong, X.-Z., ENIGMA Laterality Working Group, & Francks, F. An illustration of reproducibility in human neuroscience in the absence of selective reporting. bioRxiv. Preprint at https://doi.org/10.1101/866301 (2019).
Jahanshad, N. et al. Do candidate genes affect the brain’s white matter microstructure? large-scale evaluation of 6,165 diffusion mri scans. bioRxiv. https://doi.org/10.1101/107987 (2017).
doi: 10.1101/107987
Border, R. et al. No support for historical candidate gene or candidate gene-by-interaction hypotheses for major depression across multiple large samples. Am. J. Psychiatry 176, 376–387 (2019).
pubmed: 30845820 pmcid: 6548317
Farrell, M. S. et al. Evaluating historical candidate genes for schizophrenia. Mol. Psychiatry 20, 555–562 (2015).
pubmed: 25754081 pmcid: 25754081
Kunkle, B. W. et al. Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing. Nat. Genet 51, 414–430 (2019).
pubmed: 30820047 pmcid: 6463297
Nunes, A. et al. Using structural MRI to identify bipolar disorders – 13 site machine learning study in 3020 individuals from the ENIGMA Bipolar Disorders Working Group. Mol. Psychiatry https://doi.org/10.1038/s41380-018-0228-9 (2018).
doi: 10.1038/s41380-018-0228-9 pubmed: 30171211 pmcid: 7473838
Stein, J. L. et al. Identification of common variants associated with human hippocampal and intracranial volumes. Nat. Genet. 44, 552–561 (2012).
pubmed: 22504417 pmcid: 3635491
Hibar, D. P. et al. Common genetic variants influence human subcortical brain structures. Nature 520, 224–229 (2015).
pubmed: 25607358 pmcid: 25607358
Tilot, A. K. et al. Unearthing the evolutionary history of genetic variants influencing human cortical surface area. biorXiv. https://doi.org/10.1101/703793 (2019).
doi: 10.1101/703793
Tilot, A. K. et al. Unearthing the evolutionary history of genetic variants influencing human cortical surface area. in Abstract Presented at 49th Annual Meeting of the Society for Neuroscience Nov 3–7 (San Diego, CA, 2018).
Medland, S. E., Jahanshad, N., Neale, B. M. & Thompson, P. M. Whole-genome analyses of whole-brain data: working within an expanded search space. Nat. Neurosci. 17, 791–800 (2014).
pubmed: 24866045 pmcid: 4300949
Roshchupkin, G. V. et al. Heritability of the shape of subcortical brain structures in the general population. Nat. Commun. 7, 13738 (2016).
pubmed: 27976715 pmcid: 5172387
Adams, H. H. H. et al. Full exploitation of high dimensionality in brain imaging: The JPND working group statement and findings. Alzheimers Dement 11, 286–290 (2019).
Roshchupkin, G. V. et al. One and a half million genome wide-association studies of brain morphometry: a proof-of-concept study. Eur. Hum. Genet. Conf. (ESHG) (2019) (submitted).
Jahanshad, N. et al. Genome-wide scan of healthy human connectome discovers SPON1 gene variant influencing dementia severity. Proc. Natl Acad. Sci. USA 110, 4768–4773 (2013).
pubmed: 23471985
Thompson, P. M., Ge, T., Glahn, D. C., Jahanshad, N. & Nichols, T. E. Genetics of the connectome. Neuroimage 80, 475–488 (2013).
pubmed: 23707675 pmcid: 3905600
Thompson, P. M., Hibar, D. P., Stein, J. L., Prasad, G. & Jahanshad, N. in Micro-, Meso- and Macro-Connectomics of the Brain (eds Kennedy, H., Van Essen, D. C. & Christen, Y. (Springer: Cham (CH), 2016).
Holland, D. et al. Beyond SNP heritability: polygenicity and discoverability of phenotypes estimated with a univariate gaussian mixture model. bioRxiv. https://doi.org/10.1111/498550 (2018).
doi: 10.1111/498550
Le, B. D. & Stein, J. L. Mapping causal pathways from genetics to neuropsychiatric disorders using genome-wide imaging genetics: current status and future directions. Psychiatry Clin. Neurosci. https://doi.org/10.1111/pcn.12839 (2019).
doi: 10.1111/pcn.12839 pubmed: 30864184 pmcid: 6625892
Franke, B. et al. Genetic influences on schizophrenia and subcortical brain volumes: large-scale proof of concept. Nat. Neurosci. 19, 420–431 (2016).
pubmed: 26854805 pmcid: 4852730
Brouwer, R. M. et al. Genetic markers for brain plasticity. Presented at the 25th Organization of Human Brain Mapping Annual Meeting Jun 9–13, abstract T437 (Rome, Italy, 2019).
Brouwer, R. M. et al. Genetic influences on individual differences in longitudinal changes in global and subcortical brain volumes: results of the ENIGMA plasticity working group. Hum. Brain Mapp. 38, 4444–4458 (2017).
pubmed: 28580697 pmcid: 5572837
Smit, D. J. A. et al. Genome-wide association analysis links multiple psychiatric liability genes to oscillatory brain activity. Hum. Brain Mapp. 39, 4183–4195 (2018).
pubmed: 29947131 pmcid: 6179948
Smeland, O. B. et al. Genetic overlap between schizophrenia and volumes of hippocampus, putamen, and intracranial volume indicates shared molecular genetic mechanisms. Schizophr. Bull. 44, 854–864 (2018).
pubmed: 29136250
Brainstorm Consortium, A. V. et al. Analysis of shared heritability in common disorders of the brain. Science 360, https://doi.org/10.1126/science.aap8757 . (2018)
Lee, P. H. et al. Partitioning heritability analysis reveals a shared genetic basis of brain anatomy and schizophrenia. Mol. Psychiatry 21, 1680–1689 (2016).
pubmed: 27725656 pmcid: 5144575
Smeland, O. B. et al. Identification of genetic loci jointly influencing schizophrenia risk and the cognitive traits of verbal-numerical reasoning, reaction time, and general cognitive function. JAMA Psychiatry 74, 1065–1075 (2017).
pubmed: 28746715 pmcid: 28746715
Hibar, D. P. et al. Significant concordance of genetic variation that increases both the risk for obsessive-compulsive disorder and the volumes of the nucleus accumbens and putamen. Br. J. Psychiatry 213, 430–436 (2018).
pubmed: 29947313 pmcid: 6053271
van der Merwe, C. et al. Concordance of genetic variation that increases risk for anxiety disorders and posttraumatic stress disorders and that influences their underlying neurocircuitry. J. Affect Disord. 245, 885–896 (2019).
pubmed: 30699873
Klein, M. et al. Genetic markers of ADHD-related variations in intracranial volume. Am. J. Psychiatry 176, 228–238 (2019).
pubmed: 30818988 pmcid: 7780894
Walton, E. et al. Exploration of shared genetic architecture between subcortical brain volumes and anorexia nervosa. Mol. Neurobiol. https://doi.org/10.1007/s12035-018-1439-4 (2018).
doi: 10.1007/s12035-018-1439-4 pubmed: 30519816 pmcid: 6647452
Mufford, M. et al. Concordance of genetic variation that increases risk for tourette syndrome and that influences its underlying neurocircuitry. Transl. Psychiatry 9, 120 (2019).
pubmed: 30902966 pmcid: 6430767
Couvy-Duchesne, B. et al. A fast method for estimating statistical power of multivariate GWAS in real case scenarios: examples from the field of imaging genetics. Behav. Genet. 49, 112–121 (2019).
pubmed: 30443694
Lorenzi, M. et al. Susceptibility of brain atrophy to TRIB3 in Alzheimer’s disease, evidence from functional prioritization in imaging genetics. Proc. Natl Acad. Sci. USA 115, 3162–3167 (2018).
pubmed: 29511103
Jia, T. et al. Epigenome-wide meta-analysis of blood DNA methylation and its association with subcortical volumes: findings from the ENIGMA Epigenetics Working Group. Mol. Psychiatry https://doi.org/10.1038/s41380-019-0605-z (2019).
Sønderby, I. E. et al. Dose response of the 16p11.2 distal copy number variant on intracranial volume and basal ganglia. Mol. Psychiatry https://doi.org/10.1038/s41380-018-0118-1 (2018).
doi: 10.1038/s41380-018-0118-1 pubmed: 30283035 pmcid: 7042770
van Erp, T. G. M. et al. Subcortical brain volume abnormalities in 2028 individuals with schizophrenia and 2540 healthy controls via the ENIGMA consortium. Mol. Psychiatry 21, 547–553 (2016).
Gutman, B. A. et al. A Meta-Analysis of deep brain structural shape abnormalities in 2,763 individuals with schizophrenia compared to 3,768 healthy volunteers via the ENIGMA Consortium. Biol. Psychiatry (2020) (submitted).
Kelly, S. et al. Widespread white matter microstructural differences in schizophrenia across 4322 individuals: results from the ENIGMA Schizophrenia DTI Working Group. Mol. Psychiatry 23, 1261–1269 (2018).
pubmed: 29038599
Holleran, L. et al. The relationship between white matter microstructure and general cognitive ability in patients with schizophrenia and healthy participants in the ENIGMA consortium. Am. J. Psychiatry (2019).
Okada, N. et al. Abnormal asymmetries in subcortical brain volume in schizophrenia. Mol. Psychiatry 21, 1460–1466 (2016).
pubmed: 26782053 pmcid: 5030462
Alnæs, D. et al. Brain heterogeneity in schizophrenia and its association with polygenic risk. JAMA Psychiatry https://doi.org/10.1001/jamapsychiatry.2019.0257 (2019).
doi: 10.1001/jamapsychiatry.2019.0257 pubmed: 31365040 pmcid: 6583664
Kochunov, P., Thompson, P. M. & Hong, L. E. Toward high reproducibility and accountable heterogeneity in schizophrenia research. JAMA Psychiatry https://doi.org/10.1001/jamapsychiatry.2019.0208 (2019).
doi: 10.1001/jamapsychiatry.2019.0208 pubmed: 30969327 pmcid: 6757339
van Erp, T. G. M. et al. Reply to: New meta- and mega-analyses of magnetic resonance imaging findings in schizophrenia: do they really increase our knowledge about the nature of the disease process? Biol. Psychiatry 85, e35–e39 (2019).
pubmed: 30470561
Walton, E. et al. Positive symptoms associate with cortical thinning in the superior temporal gyrus via the ENIGMA Schizophrenia consortium. Acta Psychiatr. Scand. 135, 439–447 (2017).
pubmed: 28369804 pmcid: 5399182
Walton, E. et al. Prefrontal cortical thinning links to negative symptoms in schizophrenia via the ENIGMA consortium. Psychol. Med. 48, 82–94 (2018).
pubmed: 28545597 pmcid: 28545597
Smith, S. M. et al. Tract-based spatial statistics: voxelwise analysis of multi-subject diffusion data. Neuroimage 31, 1487–1505 (2006).
pubmed: 16624579
Jahanshad, N. et al. Multi-site genetic analysis of diffusion images and voxelwise heritability analysis: A pilot project of the ENIGMA-DTI working group. Neuroimage 81, 455–469 (2013).
pubmed: 3729717 pmcid: 3729717
Kochunov, P. et al. Integration of routine QA data into mega-analysis may improve quality and sensitivity of multisite diffusion tensor imaging studies. Hum. Brain Mapp. 39, 1015–1023 (2018).
pubmed: 29181875
van Velzen, L. S. et al. White matter disturbances in major depressive disorder: a coordinated analysis across 20 international cohorts in the ENIGMA MDD working group. Mol. Psychiatry https://doi.org/10.1038/s41380-019-0477-2 (2019).
Hibar, D. P. et al. Subcortical volumetric abnormalities in bipolar disorder. Mol. Psychiatry 21, 1710–1716 (2016).
pubmed: 26857596 pmcid: 5116479
Favre, P. et al. Widespread white matter microstructural abnormalities in bipolar disorder: evidence from mega- and meta-analyses across 3033 individuals. Neuropsychopharmacology 44, 2285–2293 (2019).
pubmed: 31434102 pmcid: 6898371
Schmaal, L. et al. Subcortical brain alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder working group. Mol. Psychiatry 21, 806–812 (2016).
pubmed: 26122586
de Kovel, C. G. F. et al. No alterations of brain structural asymmetry in Major Depressive Disorder: An ENIGMA consortium analysis. Am. J. Psychiatry 176, 1039–1049 (2019).
Han, L. K. M. et al. Brain aging in major depressive disorder: results from the ENIGMA Major Depressive Disorder working group. bioRxiv. https://doi.org/10.1101/560623 (2019).
doi: 10.1101/560623
Opel, N. et al. Brain structural abnormalities in obesity: Relation to age, genetic risk, and common psychiatric disorders - Evidence through univariate and multivariate mega-analysis including 6420 participants from the ENIGMA MDD working group. Mol. Psych (2020) (under review).
Frodl, T. et al. Childhood adversity impacts on brain subcortical structures relevant to depression. J. Psychiatr. Res. 86, 58–65 (2017).
pubmed: 27918926
Tozzi, L. et al. Interactive impact of childhood maltreatment, depression, and age on cortical brain structure: mega-analytic findings from a large multi-site cohort. Psychol. Med. 14, 1–12 (2019).
Dennis, E. L. et al. Altered white matter microstructural organization in posttraumatic stress disorder across 3,047 adults: results from the PGC-ENIGMA PTSD Consortium. Mol. J. Psychiatry https://doi.org/10.1038/s41380-019-0631-x (2019).
Gopalkumar, R. A structural covariance network analyses of cortical thickness and surface area in posttraumatic stress disorder (PTSD) from the ENIGMA Worldwide Consortium. (2020) (in preparation).
O’Leary, B. M., Xie, C. G. & Angstadt, J. T. Development of cortical vertex-based mega-analysis to study brain abnormalities in PTSD. Int. Soc. Traumatic Stress Studies (2019) (submitted).
O’Leary, B. M., Hong, X., A MR, Israel, L. & Xin W. Development of cortical vertex-based mega-analysis to study brain abnormalities in PTSD. Presented at Int. Soc. Traumatic Stress Studies Nov 8–10, abstract number #1–284 (Washington, DC, USA, 2018).
Salminen, L. et al. 108: Hippocampal subfield volumes relate to unique phenotypes of PTSD: International Analysis by the PGC-ENIGMA PTSD Working Group. Biol. Psychiatry, 85, S45 (2019).
Salminen, L. et al. Hippocampal subregion abnormalities in current and lifetime PTSD: International Analysis from the PGC-ENIGMA PTSD Working Group. in Abstract Presented at the 46th Annual Meeting of the International Neuropsychological Society Feb 14–17 (Washington, DC, 2018).
Saemann, P. et al. ENIGMA-MDD hippocampal subfield analysis of first episode and recurrent Major Depressive Disorder. Presented at the 23rd Organization of Human Brain Mapping Annual Meeting Jun 25–29, abstract 1254 (Vancouver, Canada, 2017).
Saemann, P. G. et al. FreeSurfer based segmentation of hippocampal subfields: a review of methods and applications, with a novel quality control procedure and usefulness for ENIGMA studies and other collaborative efforts. (2018) (submitted).
Mackey, S. et al. Genetic imaging consortium for addiction medicine: from neuroimaging to genes. Prog. Brain Res 224, 203–223 (2016).
pubmed: 26822360
Chye, Y. et al. Subcortical surface morphometry in substance dependence: an ENIGMA addiction working group study. Addiction Biol. e12830 (2019).
Conrod, P. et al. Cortical and subcortical differences between alcohol dependent individuals and controls: meta analysis results from the ENIGMA-Addiction Working Group. Biol. Psychiatry 81, S41 (2017).
de Wit, S. J. et al. Multicenter voxel-based morphometry mega-analysis of structural brain scans in obsessive-compulsive disorder. Am. J. Psychiatry 171, 340–349 (2014).
pubmed: 24220667
Boedhoe, P. S. W. et al. Distinct subcortical volume alterations in pediatric and adult OCD: a worldwide meta- and mega-analysis. Am. J. Psychiatry 174, 60–69 (2017).
pubmed: 27609241
Bruin, W. B. et al. Structural neuroimaging biomarkers for obsessive-compulsive disorder in the ENIGMA-OCD consortium: medication matters. Preprint at https://doi.org/10.1101/19012567 (2019).
Kong, X.-Z. et al. Mapping cortical and subcortical asymmetry in obsessive-compulsive disorder: Findings from the ENIGMA Consortium. Biol. Psychiatry https://doi.org/10.1016/j.biopsych.2019.04.022 (2019).
Hoogman, M. et al. Subcortical brain volume differences in participants with attention deficit hyperactivity disorder in children and adults: a cross-sectional mega-analysis. Lancet Psychiatry 4, 310–319 (2017).
pubmed: 28219628 pmcid: 5933934
Hess, J. L., Akutagava-Martins, G. C., Patak, J. D., Glatt, S. J. & Faraone, S. V. Why is there selective subcortical vulnerability in ADHD? Clues from postmortem brain gene expression data. Mol. Psychiatry 23, 1787–1793 (2018).
pubmed: 29180674
Shaw, P. et al. A multicohort, longitudinal study of cerebellar development in attention deficit hyperactivity disorder. J. Child Psychol. Psychiatry 59, 1114–1123 (2018).
pubmed: 29693267 pmcid: 6158081
Zhang-James, Y. et al. Machine learning classification of attention-deficit/hyperactivity disorder using structural MRI data. bioRxiv. https://doi.org/10.1101/546671 (2019).
doi: 10.1101/546671
Gottesman, I. I. & Gould, T. D. The endophenotype concept in psychiatry: etymology and strategic intentions. Am. J. Psychiatry 160, 636–645 (2003).
pubmed: 12668349
Flint, J. & Munafò, M. R. The endophenotype concept in psychiatric genetics. Psychol. Med. 37, 163–180 (2007).
pubmed: 16978446
Postema, M. C. et al. Altered structural brain asymmetry in autism spectrum disorder in a study of 54 datasets. Nat. Commun. 10, 4658 (2019).
Namazova-Baranova, L. et al. Cortical Morphometry in Gaucher Disease: Findings from the ENIGMA Storage Disease working group. Presented at the 23rd Organization of Human Brain Mapping Annual Meeting Jun 25–29, abstract 1275 (Vancouver, Canada, 2017).
Namazova-Baranova, L. et al. Cortical Morphometry and White Matter Integrity in Children with Hepatic Glycogen Storage Disease. Presented at the 23rd Organization of Human Brain Mapping Annual Meeting Jun 25–29, abstract 1277 (Vancouver, Canada, 2017).
van der Meer, D. et al. Association of copy number variation of the 15q11.2 region with cortical and subcortical morphology and cognition. JAMA Psychiatry https://doi.org/10.1001/jamapsychiatry.2019.3779 (2019).
doi: 10.1001/jamapsychiatry.2019.3779 pubmed: 30969333 pmcid: 6822096
Ching, C. R. K., Thompson, P. M. & Bearden, C. E., for the ENIGMA 22q11.2 Deletion Syndrome Working Group. Convergent subcortical brain alterations in 22q11.2 deletion syndrome and schizophrenia. Presented at the 24th Organization of Human Brain Mapping Annual Meeting Jun 17–21, abstract 1569 (Singapore, 2018).
Stefansson, H. et al. CNVs conferring risk of autism or schizophrenia affect cognition in controls. Nature 505, 361–366 (2014).
pubmed: 24352232 pmcid: 24352232
Crawford, K. et al. Medical consequences of pathogenic CNVs in adults: analysis of the UK Biobank. J. Med. Genet. 56, 131–138 (2019).
pubmed: 30343275
King, J. A., Frank, G. K. W., Thompson, P. M. & Ehrlich, S. Structural neuroimaging of anorexia nervosa: future directions in the quest for mechanisms underlying dynamic alterations. Biol. Psychiatry 83, 224–234 (2018).
pubmed: 28967386 pmcid: 28967386
Bas-Hoogendam, J. M. et al. Voxel-based morphometry multi-center mega-analysis of brain structure in social anxiety disorder. Neuroimage Clin. 16, 678–688 (2017).
pubmed: 30140607 pmcid: 6103329
Bas-Hoogendam, J. M. et al. Subcortical brain volumes, cortical thickness and cortical surface area in families genetically enriched for social anxiety disorder – A multiplex multigenerational neuroimaging study. EBioMedicine 36, 410–428 (2018).
pubmed: 30266294 pmcid: 6197574
Groenewold, N. et al. F27. Subcortical volumes in social anxiety disorder: preliminary results from enigma-anxiety. Biol. Psychiatry 83, S247–S248 (2018).
Shiroishi, M. S. et al. Brain cortical structural differences between non-central nervous system cancer patients treated with and without chemotherapy compared to non-cancer controls: a cross-sectional pilot MRI study using clinically-indicated scans. Proc. SPIE Int. Soc. Opt. Eng. 10572 https://doi.org/10.1117/12.2285971 (2017).
Shiroishi, M. S. et al. Brain morphometry in prostate cancer survivors from the ENIGMA Cancer & Chemotherapy Working Group. Presented at the 24th Organization of Human Brain Mapping Annual Meeting Jun 17–21, abstract 1321 (Singapore, 2018).
Altmann, A. et al. A systems-level analysis highlights microglial activation as a modifying factor in common forms of human epilepsy. bioRxiv. https://doi.org/10.1101/470518 (2018).
doi: 10.1101/470518
Wilde, E. A., Dennis, E. L. & Tate, D. F. The ENIGMA Brain Injury Working Group: Approach, Challenges, and Potential Benefits. Brain Imaging Behav. (Special Issue on ENIGMA Brain Injury). Preprint at https://doi.org/10.31234/osf.io/t96xb (2019) (submitted).
Olsen, A. et al. Toward a Global and Reproducible Science for Brain Imaging in Neurotrauma: The ENIGMA Adult Moderate/Severe Traumatic Brain Injury Working Group. Brain Imaging Behav. (Special Issue on ENIGMA Brain Injury). Preprint at https://doi.org/10.31234/osf.io/jnsb2. (2019) (submitted).
Dennis, E. L. et al. ENIGMA pediatric msTBI: preliminary results from meta-analysis of diffusion MRI. in14th International Symposium on Medical Information Processing and Analysis. (International Society for Optics and Photonics, 2018).
Dennis, E. L. et al. Brain Imaging in Young TBI Patients: A Coordinated Effort Towards Individualized Predictors from the ENIGMA Pediatric msTBI Group. Brain Imaging Behav. (Special Issue on ENIGMA Brain Injury). Preprint at https://doi.org/10.31234/osf.io/y2txh (2019) (submitted).
Dennis, E. L. et al. ENIGMA military brain injury: a coordinate meta-analysis of diffusion MRI from multiple cohorts. Proc. IEEE Int Symp. Biomed. Imaging 2018, 1386–1389 (2018).
pubmed: 30034577 pmcid: 6049824
Dennis, E. L. et al. ENIGMA Military Brain Injury: A Preliminary Meta-Analysis of Diffusion MRI Measures. Presented at the 70th Annual Meeting of the American Academy of Neurology Apr 21–27, abstract S46.006 (Los Angeles, CA, 2018).
Dennis, E. L. et al. ENIGMA Military Brain Injury: Altered Subcortical Volume Revealed by Mega-Analysis. Presented at the 71st Annual Meeting of the American Academy of Neurology May 4–11, abstract (Philadelphia, PA, 2018).
Tate, D. F. et al. Coordinating global multi-site studies of military-relevant traumatic brain injury: Opportunities, challenges, and harmonization guidelines. Brain Imaging Behav. (Special Issue on ENIGMA Brain Injury). Preprint at https://doi.org/10.31234/osf.io/d4qs8 (2019) (submitted).
Koerte, I. K. et al. Neuroimaging of Sport-Related Brain Injury: Challenges and Recommendations from the ENIGMA Sports-Related Brain Injury group. Brain Imaging and Behavior (Special Issue on ENIGMA Brain Injury) (2019) (in preparation).
Esopenko, C. et al. Harmonization of Measures to Assess IPV-Related Head Trauma: Recommendations from the ENIGMA IPV Working Group. Brain Imaging Behav. (Special Issue on ENIGMA Brain Injury). Preprint at https://doi.org/10.31234/osf.io/3xzwg (2019) (submitted).
Bartnik-Olson, B. et al. The Clinical Utility Of Magnetic Resonance Spectroscopy In Traumatic Brain Injury: Recommendations from the ENIGMA MRS Working Group. Brain Imaging Behav. (Special Issue on ENIGMA Brain Injury). Preprint at https://doi.org/10.31234/osf.io/gesvh (2019) (submitted).
van der Werf, Y. et al. International mega-analysis of cortical and subcortical morphometry in Parkinson’s Disease: ENIGMA-PD. Presented at the 14th International Conference of Alzheimer’s and Parkinson’s Diseases Mar 26–31, oral presentation at symposium 35 (Lisbon, Portugal, 2019).
van der Werf, Y. D. et al. ENIGMA-Parkinson’s Disease: An International mega-analysis of cortical and subcortical morphometry in Parkinson’s patients versus healthy controls. Presented at the 25th Organization of Human Brain Mapping Annual Meeting Jun 9–13, abstract W273 (Rome, Italy, 2019).
Nir, T. M. et al. Smaller limbic brain volumes are associated with greater immunosuppression in over 1000 HIV-infected adults across five continents: findings from the ENIGMA-HIV Working Group. Preprint at https://doi.org/10.1101/724583 (2019).
Cole, J. H. et al. Increased brain-predicted aging in treated HIV disease. Neurology 88, 1349–1357 (2017).
pubmed: 28258081 pmcid: 5379929
Liew, S.-L. et al. A large, open source dataset of stroke anatomical brain images and manual lesion segmentations. Sci. Data 5, 180011 (2018).
pubmed: 29461514 pmcid: 5819480
Ito, K. L., Kumar, A., Zavaliangos-Petropulu, A., Cramer, S. C. & Liew, S.-L. Pipeline for Analyzing Lesions After Stroke (PALS). Front. Neuroinform. 12, 63 (2018).
pubmed: 30319385 pmcid: 6165891
Ito, K. L., Kim, H. & Liew, S.-L. A comparison of automated lesion segmentation approaches for chronic stroke T1‐weighted MRI data. Hum. Brain Mapp. 40, 4669–4685 (2019).
pubmed: 31350795 pmcid: 6851560
Liew, S.-L. et al. Abstract TMP48: Subcortical volumes associated with post-stroke motor performance vary across impairment severity, time since stroke, and lesion laterality: an ENIGMA Stroke Recovery Analysis. Stroke 49(Suppl_1) https://doi.org/10.1161/str.49.suppl_1.TMP48 (2018).
Liew, S.-L. et al. Abstract 14: Effects of lesion laterality on post-stroke motor performance: An ENIGMA Stroke Recovery Analysis. Stroke 48(Suppl 1) https://www.ahajournals.org/doi/10.1161/str.48.suppl_1.14 (2017).
Ito, K. L., Zavaliangos-Petropulu, A., Cramer, S. C. & Liew, S.-L. Effective connectivity of the ipsilesional action observation network after stroke. Presented at the 24th Organization of Human Brain Mapping Annual Meeting Jun 17–21, abstract (Singapore, 2018).
Zavaliangos-Petropulu, A., Jahanshad, N., Thompson, P. M. & Liew, S.-L. Evaluating stroke lesion overlap with subcortical structures and post-stroke motor performance. Presented at the 25th Organization of Human Brain Mapping Annual Meeting Jun 9–13, abstract M203 (Rome, Italy, 2019).
Zavaliangos-Petropulu, A. et al. Subcortical brain shape differences relate to post-stroke motor behavior. Presented at the American Society of Neurorehabilitation Conference Annual Meeting Nov 9–10, abstract F12 (Baltimore, MD, 2017).
Kochunov, P. et al. Heterochronicity of white matter development and aging explains regional patient control differences in schizophrenia. Hum. Brain Mapp. 37, 4673–4688 (2016).
pubmed: 27477775 pmcid: 5118078
Nir, T. M. et al. Effects of Diffusion MRI model and harmonization on the consistency of findings in an international multi-cohort HIV neuroimaging study. In: Bonet-Carne, E., Grussu, F., Ning, L., Sepehrband, F. & Tax, C. (eds) Computational Diffusion MRI. MICCAI 2019. Mathematics and Visualization. (Springer, Cham, 2019) https://doi.org/10.1007/978-3-030-05831-9_17 .
Piras, F. et al. Selective white matter microstructure and its relation to clinical features of obsessive-compulsive disorder: findings from the ENIGMA OCD Working Group. bioRxiv. https://doi.org/10.1101/855916 (2019).
doi: 10.1101/855916
Ho, T. C. et al. Subcortical shape alterations in major depressive disorder: findings from the ENIGMA Major Depressive Disorder Working Group. Hum. Brain Mapp. Preprint at https://doi.org/10.1101/534370 (2019) (submitted).
Petrov, D. et al. Machine learning for large-scale quality control of 3D shape models in neuroimaging. bioRxiv. https://doi.org/10.1101/166496 (2017).
doi: 10.1101/166496
Petrov, D. et al. Deep Learning for Quality Control of Subcortical Brain 3D Shape Modelsin Shape in Medical Imaging. 268–276 (Springer International Publishing, 2018).
Fouche, J.-P. et al. Shape analysis of subcortical structures in obsessive compulsive disorder: a multi-site analysis of the OCD Brain Imaging Consortium. (2020) (in preparation).
Ching, C. R. K. et al. Subcortical Shape and Volumetric Findings from ENIGMA 22q11.2 Working Group (N = 778). Presented at the 23rd Organization of Human Brain Mapping Annual Meeting Jun 25–29, abstract 3318 (Vancouver, Canada, 2017).
Ching, C. R. K., Gutman, B. A., Hibar, D. P., Thompson, P. M. & Andreassen, O. A. for the ENIGMA Bipolar Disorder Working Group. Subcortical Shape Analysis from the ENIGMA Bipolar Disorder Working Group (N = 3,028). Presented at the 23rd Organization of Human Brain Mapping Annual Meeting Jun 25–29, abstract 1205 (Vancouver, Canada, 2017).
Yun, J.-Y. et al. Brain structural covariance networks in obsessive-compulsive disorder: a graph analysis from the ENIGMA Consortium. Brain 143, 684–700 (2020).
pubmed: 32040561 pmcid: 7009583
Pizzagalli, F. et al. The reliability and heritability of cortical folds and their genetic correlations across hemispheres. bioRxiv. https://doi.org/10.1101/795591 (2019).
Haukvik, U. K. et al. In vivo hippocampal subfield volumes in bipolar disorder – a mega-analysis from the ENIGMA consortium. (2020) (in preparation).
Button, K. S. Double-dipping revisited. Nat. Neurosci. 22, 688–690 (2019).
pubmed: 31011228
Button, K. S. et al. Power failure: why small sample size undermines the reliability of neuroscience. Nat. Rev. Neurosci. 14, 365–376 (2013).
Ioannidis, J. P. A. & Khoury, M. J. Evidence-based medicine and big genomic data. Hum. Mol. Genet. 27, R2–R7 (2018).
pubmed: 29474574 pmcid: 6247896
Poldrack, R. A. et al. Scanning the horizon: towards transparent and reproducible neuroimaging research. Nat. Rev. Neurosci. 18, 115–126 (2017).
pubmed: 28053326 pmcid: 6910649
Hallquist, M. N. & Hillary, F. G. Graph theory approaches to functional network organization in brain disorders: a critique for a brave new small-world. Netw. Neurosci. 3, 1–26 (2019).
pubmed: 30793071
Gorgolewski, K. J. et al. NeuroVault.org: a web-based repository for collecting and sharing unthresholded statistical maps of the human brain. Front. Neuroinform. 9, 8 (2015).
pubmed: 25914639 pmcid: 4392315
Poldrack, R. A. & Gorgolewski, K. J. OpenfMRI: open sharing of task fMRI data. Neuroimage 144, 259–261 (2017).
pubmed: 26048618
Zuo, X.-N. et al. An open science resource for establishing reliability and reproducibility in functional connectomics. Sci. Data 1, 140049 (2014).
pubmed: 25977800 pmcid: 4421932
Kong, X.-Z. et al. Mapping cortical brain asymmetry in 17,141 healthy individuals worldwide via the ENIGMA Consortium. Proc. Natl Acad. Sci. USA 115, E5154–E5163 (2018).
pubmed: 29764998
Salminen, L. E. et al. Hippocampal Subfields in PTSD: Preliminary Results from the ENIGMA PTSD Working Group. Presented at the 23rd Organization of Human Brain Mapping Annual Meeting Jun 25–29, abstract 1138 (Vancouver, Canada, 2017).
Elliott, L. T. et al. Genome-wide association studies of brain imaging phenotypes in UK Biobank. Nature 562, 210–216 (2018).
pubmed: 6786974 pmcid: 6786974
Ferguson, A. R., Nielson, J. L., Cragin, M. H., Bandrowski, A. E. & Martone, M. E. Big data from small data: data-sharing in the ‘long tail’ of neuroscience. Nat. Neurosci. 17, 1442–1447 (2014).
pubmed: 25349910 pmcid: 4728080
Milham, M. P. et al. An open resource for non-human primate imaging. Neuron 100, 61–74.e2 (2018).
pubmed: 30269990 pmcid: 6231397
Palk, A., Illes, J., Thompson, P. M. & Stein, D. J. Ethical issues in global imaging genetics collaborations. NeuroImage (2019) (submitted).
Adhikari, B. M. et al. Comparison of heritability estimates on resting state fMRI connectivity phenotypes using the ENIGMA analysis pipeline. Hum. Brain Mapp. 39, 4893–4902 (2018).
pubmed: 30052318 pmcid: 6218292
Adhikari, B. M. et al. Heritability estimates on resting state fMRI data using ENIGMA analysis pipeline. Pac. Symp. Biocomput. 23, 307–318 (2018).
pubmed: 29218892 pmcid: 5728672
Adhikari, B. M. et al. Effects of ketamine and midazolam on resting state connectivity and comparison with ENIGMA connectivity deficit patterns in schizophrenia. Hum. Brain Mapp. 41, 767–778 (2020).
pubmed: 31633254
Veer, I. M., Waller, L., Lett, T. A. P., Erk, S. & Walter, H. ENIGMA task-based fMRI: A workgroup studying the genetic basis of task-evoked brain activity. Presented at the 25th Organization of Human Brain Mapping Annual Meeting Jun 9–13, abstract W293 (Rome, Italy, 2019).
Plis, S. M. et al. COINSTAC: a privacy enabled model and prototype for leveraging and processing decentralized brain imaging data. Front. Neurosci. 10, 365 (2016).
pubmed: 27594820 pmcid: 4990563
Boedhoe, P. S. W. et al. An empirical comparison of meta- and mega-analysis with data from the ENIGMA obsessive-compulsive disorder working group. Front. Neuroinf. 12, 102 (2019).
Reardon, S. The largest study involving transgender people is providing long-sought insights about their health. Nature 568, 446–449 (2019).
pubmed: 31019329
Mueller, S., Thompson, P. & Luders E., for The Enigma Transgender Persons Working Group. An initiative to combine MRI data in transgender persons to examine structural brain differences: preliminary findings from the ENIGMA transgender persons working group. Presented at the 3rd biennial European Professional Association for Transgender Health Conference Apr 11–13, oral presentation (Rome, Italy, 2019).
Aristotle. Metaphysics, book 2 (~350 BCE).
Adams, H. H. H. et al. Novel genetic loci underlying human intracranial volume identified through genome-wide association. Nat. Neurosci. 19, 1569–1582 (2016).
pubmed: 27694991 pmcid: 5227112
Nir, T. M. et al. CD4 counts predict brain white matter integrity in people living with HIV: A meta-analysis by the ENIGMA HIV working group. Presented at the Cognitive Neuroscience Society (CNS) Annual Meeting Mar 28–31, abstract D104 (San Francisco, CA, 2015).
Fouche, J. P. et al. A meta-analysis by the ENIGMA-HIV working group: CD4 counts predict subcortical volume loss in HIV-positive individuals. Presented at the 21st Organization for Human Brain Mapping Annual Meeting Jun 14–18, abstract 3271 (Honolulu, HI, 2015).
Renteria, M. E. et al. Subcortical brain structure and suicidal behaviour in major depressive disorder: a meta-analysis from the ENIGMA-MDD working group. Transl. Psychiatr 7, e1116 (2017).
Hibar, D. et al. Novel genetic loci associated with hippocampal volume. Nat. Commun. 8, 13624 (2017).
pubmed: 28098162 pmcid: 5253632
Guadalupe, T. et al. Human subcortical brain asymmetries in 15,847 people worldwide reveal effects of age and sex. Brain Imaging Behav. 11, 1497–1514 (2017).
pubmed: 27738994
Dima, D. et al. Subcortical volumes trajectories across the lifespan: Data from 18,605 healthy individuals aged 3–90 years. Hum Brain Mapp (2020) (submitted).
Frangou, S. et al. Subcortical volumes across the lifespan: Normative data from 10,144 individuals aged 3–90 years. Hum Brain Mapp (2020) (submitted).

Auteurs

Paul M Thompson (PM)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA. pthomp@usc.edu.

Neda Jahanshad (N)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Christopher R K Ching (CRK)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Lauren E Salminen (LE)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Sophia I Thomopoulos (SI)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Joanna Bright (J)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Bernhard T Baune (BT)

Department of Psychiatry, University of Münster, Münster, Germany.
Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia.
The Florey Institute of Neuroscience and Mental Health, The University of Melbourne, Melbourne, VIC, Australia.

Sara Bertolín (S)

Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain.

Janita Bralten (J)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.

Willem B Bruin (WB)

Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Robin Bülow (R)

Institute for Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.

Jian Chen (J)

Department of Computer Science and Engineering, The Ohio State University, Columbus, OH, USA.

Yann Chye (Y)

Turner Institute for Brain and Mental Health, School of Psychological Sciences, Monash University, Clayton, VIC, Australia.

Udo Dannlowski (U)

Department of Psychiatry, University of Münster, Münster, Germany.

Carolien G F de Kovel (CGF)

Biometris Wageningen University and Research, Wageningen, The Netherlands.
Language & Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.

Gary Donohoe (G)

The Center for Neuroimaging and Cognitive Genomics, School of Psychology, National University of Ireland, Galway, Ireland.

Lisa T Eyler (LT)

Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA.
Desert-Pacific Mental Illness Research, Education, and Clinical Center, VA San Diego Healthcare System, San Diego, CA, USA.

Stephen V Faraone (SV)

Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA.

Pauline Favre (P)

INSERM Unit 955 Team 15 'Translational Psychiatry', Créteil, France.
NeuroSpin, UNIACT Lab, Psychiatry Team, CEA Saclay, Gif-Sur-Yvette, France.

Courtney A Filippi (CA)

National Institute of Mental Health, National of Health, Bethesda, MD, USA.

Thomas Frodl (T)

Department of Psychiatry and Psychotherapy, Otto von Guericke University Magdeburg, Magdeburg, Germany.
Department of Psychiatry, Trinity College Dublin, Dublin, Ireland.
German Center for Neurodegenerative Diseases (DZNE), Magdeburg, Germany.

Daniel Garijo (D)

Information Sciences Institute, University of Southern California, Marina del Rey, CA, USA.

Yolanda Gil (Y)

Information Sciences Institute, University of Southern California, Marina del Rey, CA, USA.
Department of Computer Science, University of Southern California, Los Angeles, CA, USA.

Hans J Grabe (HJ)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
German Center for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany.

Katrina L Grasby (KL)

Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Tomas Hajek (T)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
National Institute of Mental Health, Klecany, Czech Republic.

Laura K M Han (LKM)

Department of Psychiatry, Amsterdam University Medical Centers, VU University Medical Center, GGZ inGeest, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Sean N Hatton (SN)

Center for Multimodal Imaging and Genetics, University of California, San Diego, La Jolla, CA, USA.
Brain and Mind Centre, University of Sydney, Sydney, Australia.

Kevin Hilbert (K)

Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.

Tiffany C Ho (TC)

Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, CA, USA.
Department of Psychiatry & Weill Institute for Neurosciences, University of California, San Francisco, San Francisco, CA, USA.

Laurena Holleran (L)

The Center for Neuroimaging and Cognitive Genomics, School of Psychology, National University of Ireland, Galway, Ireland.

Georg Homuth (G)

Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.

Norbert Hosten (N)

Institute for Diagnostic Radiology and Neuroradiology, University Medicine Greifswald, Greifswald, Germany.

Josselin Houenou (J)

INSERM Unit 955 Team 15 'Translational Psychiatry', Créteil, France.
NeuroSpin, UNIACT Lab, Psychiatry Team, CEA Saclay, Gif-Sur-Yvette, France.
APHP, Mondor University Hospitals, School of Medicine, DMU Impact, Psychiatry Department, Créteil, France.

Iliyan Ivanov (I)

Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Tianye Jia (T)

Institute of Science and Technology for Brain-Inspired Intelligence, Fudan University, Shanghai, China.
MOE Key Laboratory of Computational Neuroscience and Brain-Inspired Intelligence, Fudan University, Shanghai, China.
Centre for Population Neuroscience and Precision Medicine (PONS), MRC SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Sinead Kelly (S)

Department of Psychiatry, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA, USA.
Department of Psychiatry, Brigham and Women's Hospital, Boston, MA, USA.

Marieke Klein (M)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
Department of Psychiatry, UMC Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Jun Soo Kwon (JS)

Department of Psychiatry, Seoul National University College of Medicine, Seoul, Republic of Korea.
Department of Brain and Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, Republic of Korea.

Max A Laansma (MA)

Department of Anatomy & Neurosciences, Amsterdam UMC, Location VUmc, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Jeanne Leerssen (J)

Department of Sleep and Cognition, Netherlands Institute for Neuroscience, Amsterdam, The Netherlands.

Ulrike Lueken (U)

Department of Psychology, Humboldt-Universität zu Berlin, Berlin, Germany.

Abraham Nunes (A)

Department of Psychiatry, Dalhousie University, Halifax, NS, Canada.
Faculty of Computer Science, Dalhousie University, Halifax, NS, Canada.

Joseph O' Neill (JO)

Child & Adolescent Psychiatry, University of California, Los Angeles, Los Angeles, CA, USA.

Nils Opel (N)

Department of Psychiatry, University of Münster, Münster, Germany.

Fabrizio Piras (F)

Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.

Federica Piras (F)

Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.

Merel C Postema (MC)

Language & Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.

Elena Pozzi (E)

Melbourne Neuropsychiatry Centre, Department of Psychiatry, The University of Melbourne, Melbourne, VIC, Australia.
Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia.

Natalia Shatokhina (N)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Carles Soriano-Mas (C)

Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain.
CIBERSAM-G17, Madrid, Spain.
Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Barcelona, Spain.

Gianfranco Spalletta (G)

Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.
Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, TX, USA.

Daqiang Sun (D)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA.
Department of Mental Health, Veterans Affairs Greater Los Angeles Healthcare System, Los Angeles, CA, USA.

Alexander Teumer (A)

Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.

Amanda K Tilot (AK)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Leonardo Tozzi (L)

Department of Psychiatry & Behavioral Sciences, Stanford University, Stanford, CA, USA.

Celia van der Merwe (C)

Stanley Center for Psychiatric Research, The Broad Institute, Cambridge, MA, USA.
Analytic and Translational Genetics Unit, Massachusetts General Hospital, Boston, MA, USA.

Eus J W Van Someren (EJW)

Department of Sleep and Cognition, Netherlands Institute for Neuroscience, Amsterdam, The Netherlands.
Psychiatry and Integrative Neurophysiology, VU University, Amsterdam UMC, Amsterdam, The Netherlands.

Guido A van Wingen (GA)

Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Henry Völzke (H)

Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
German Centre for Cardiovascular Research, Partner Site Greifswald, Greifswald, Germany.

Esther Walton (E)

Department of Psychology, University of Bath, Bath, UK.

Lei Wang (L)

Psychiatry and Behavioral Sciences, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.
Radiology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA.

Anderson M Winkler (AM)

National Institute of Mental Health, National of Health, Bethesda, MD, USA.

Katharina Wittfeld (K)

Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
German Center for Neurodegenerative Diseases (DZNE), Site Rostock/Greifswald, Greifswald, Germany.

Margaret J Wright (MJ)

Queensland Brain Institute, University of Queensland, Brisbane, QLD, Australia.
Centre for Advanced Imaging, University of Queensland, Brisbane, QLD, Australia.

Je-Yeon Yun (JY)

Seoul National University Hospital, Seoul, Republic of Korea.
Yeongeon Student Support Center, Seoul National University College of Medicine, Seoul, Republic of Korea.

Guohao Zhang (G)

Department of Computer Science and Electrical Engineering, University of Maryland, Baltimore County, MD, USA.

Yanli Zhang-James (Y)

Departments of Psychiatry and of Neuroscience and Physiology, SUNY Upstate Medical University, Syracuse, NY, USA.
Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, NY, USA.

Bhim M Adhikari (BM)

Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.

Ingrid Agartz (I)

Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health & Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Department of Clinical Neuroscience, Centre for Psychiatric Research, Karolinska Institutet, Stockholm, Sweden.
Department of Psychiatric Research, Diakonhjemmet Hospital, Oslo, Norway.

Moji Aghajani (M)

Department of Psychiatry, Amsterdam UMC, Location VUmc, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Department of Research & Innovation, GGZ InGeest, Amsterdam, The Netherlands.

André Aleman (A)

University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

Robert R Althoff (RR)

Psychiatry, Pediatrics, and Psychological Sciences, University of Vermont, Burlington, VT, USA.

Andre Altmann (A)

Centre for Medical Image Computing (CMIC), Department of Medical Physics and Biomedical Engineering, University College London, London, UK.

Ole A Andreassen (OA)

Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health & Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

David A Baron (DA)

Provost and Senior Vice President, Western University of Health Sciences, Pomona, CA, USA.

Brenda L Bartnik-Olson (BL)

Department of Radiology, Loma Linda University Medical Center, Loma Linda, CA, USA.

Janna Marie Bas-Hoogendam (J)

Institute of Psychology, Leiden University, Leiden, The Netherlands.
Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.
Leiden Institute for Brain and Cognition, Leiden, The Netherlands.

Arielle R Baskin-Sommers (AR)

Department of Psychology, Yale University, New Haven, CT, USA.

Carrie E Bearden (CE)

Department of Psychiatry and Biobehavioral Sciences, Semel Institute for Neuroscience and Human Behavior, University of California, Los Angeles, Los Angeles, CA, USA.
Department of Psychology, University of California, Los Angeles, CA, USA.

Laura A Berner (LA)

Icahn School of Medicine at Mount Sinai, New York, NY, USA.

Premika S W Boedhoe (PSW)

Department of Psychiatry, Amsterdam UMC, Location VUmc, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Rachel M Brouwer (RM)

Department of Psychiatry, UMC Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Jan K Buitelaar (JK)

Department of Cognitive Neuroscience, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.

Karen Caeyenberghs (K)

Cognitive Neuroscience Unit, School of Psychology, Deakin University, Burwood, VIC, Australia.

Charlotte A M Cecil (CAM)

Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Centre, Rotterdam, The Netherlands.
Department of Epidemiology, Erasmus Medical Centre, Rotterdam, The Netherlands.

Ronald A Cohen (RA)

Center for Cognitive Aging and Memory, University of Florida, Gainesville, FL, USA.
Clinical and Health Psychology, Gainesville, FL, USA.

James H Cole (JH)

Centre for Medical Image Computing (CMIC), Department of Computer Science, University College London, London, UK.
Dementia Research Centre, Institute of Neurology, University College London, London, UK.

Patricia J Conrod (PJ)

Universite de Montreal, Centre de Recherche CHU Ste-Justine, Montreal, QC, Canada.

Stephane A De Brito (SA)

School of Psychology and Centre for Human Brain Health, University of Birmingham, Birmingham, UK.

Sonja M C de Zwarte (SMC)

Department of Psychiatry, UMC Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Emily L Dennis (EL)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
Department of Neurology, University of Utah, Salt Lake City, UT, USA.
Psychiatry Neuroimaging Laboratory, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.

Sylvane Desrivieres (S)

Social, Genetic & Developmental Psychiatry Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Danai Dima (D)

Department of Psychology, School of Arts and Social Sciences, City, University of London, London, UK.
Department of Neuroimaging, Institute of Psychology, Psychiatry and Neurosciences, King's College London, London, UK.

Stefan Ehrlich (S)

Division of Psychological and Social Medicine and Developmental Neurosciences, Faculty of Medicine, TU Dresden, Dresden, Germany.

Carrie Esopenko (C)

Department of Rehabilitation and Movement Sciences, School of Health Professions, Rutgers Biomedical Health Sciences, Newark, NJ, USA.

Graeme Fairchild (G)

Department of Psychology, University of Bath, Bath, UK.

Simon E Fisher (SE)

Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
Language & Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.

Jean-Paul Fouche (JP)

Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.
SU/UCT MRC Unit on Risk & Resilience in Mental Disorders, University of Stellenbosch, Stellenbosch, South Africa.

Clyde Francks (C)

Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
Language & Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.

Sophia Frangou (S)

Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
University of British Columbia, Vancouver, Canada.

Barbara Franke (B)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
Department of Psychiatry, Radboud University Medical Center, Nijmegen, The Netherlands.

Hugh P Garavan (HP)

Department of Psychiatry, University of Vermont, Burlington, VT, USA.

David C Glahn (DC)

Department of Psychiatry, Boston Children's Hospital and Harvard Medical School, Boston, MA, USA.
Olin Neuropsychiatric Research Center, Institute of Living, Hartford, CT, USA.

Nynke A Groenewold (NA)

Department of Psychiatry and Mental Health, University of Cape Town, Cape Town, South Africa.

Tiril P Gurholt (TP)

Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health & Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.

Boris A Gutman (BA)

Biomedical Engineering, Illinois Institute of Technology, Chicago, IL, USA.
Institute for Information Transmission Problems, Kharkevich Institute, Moscow, Russian Federation.

Tim Hahn (T)

Department of Psychiatry, University of Münster, Münster, Germany.

Ian H Harding (IH)

Turner Institute for Brain and Mental Health & School of Psychological Sciences, Monash University, Melbourne, VIC, Australia.

Dennis Hernaus (D)

Department of Psychiatry & Neuropsychology, School for Mental Health and Neuroscience, Maastricht University, Maastricht, The Netherlands.

Derrek P Hibar (DP)

Genentech, Inc., South San Francisco, CA, USA.

Frank G Hillary (FG)

Department of Psychology, Penn State University, University Park, PA, USA.
Social Life and Engineering Sciences Imaging Center, University Park, PA, USA.

Martine Hoogman (M)

Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.

Hilleke E Hulshoff Pol (HE)

Department of Psychiatry, UMC Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.

Maria Jalbrzikowski (M)

Department of Psychiatry, University of Pittsburgh, Pittsburgh, PA, USA.

George A Karkashadze (GA)

Research and Scientific Institute of Pediatrics and Child Health, CCH RAS, Ministry of Science and Higher Education, Moscow, Russian Federation.

Eduard T Klapwijk (ET)

Institute of Psychology, Leiden University, Leiden, The Netherlands.
Leiden Institute for Brain and Cognition, Leiden, The Netherlands.

Rebecca C Knickmeyer (RC)

Department of Pediatrics, Michigan State University, East Lansing, MI, USA.
Institute for Quantitative Health Science and Engineering, East Lansing, MI, USA.
Department of Psychiatry, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Peter Kochunov (P)

Department of Psychiatry, University of Maryland School of Medicine, Baltimore, MD, USA.

Inga K Koerte (IK)

Psychiatry Neuroimaging Laboratory, Brigham & Women's Hospital, Harvard Medical School, Boston, MA, USA.
CBRAIN, Department of Child and Adolescent Psychiatry, Psychosomatics, and Psychotherapy, Ludwig-Maximilians-Universität München, Munich, Germany.

Xiang-Zhen Kong (XZ)

Language & Genetics Department, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.

Sook-Lei Liew (SL)

Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Chan Division of Occupational Science and Occupational Therapy, Los Angeles, CA, USA.

Alexander P Lin (AP)

Center for Clinical Spectroscopy, Brigham and Women's Hospital, Boston, MA, USA.
Harvard Medical School, Boston, MA, USA.

Mark W Logue (MW)

National Center for PTSD at Boston VA Healthcare System, Boston, MA, USA.
Department of Psychiatry, Boston University School of Medicine, Boston, MA, USA.
Biomedical Genetics, Boston University School of Medicine, Boston, MA, USA.

Eileen Luders (E)

School of Psychology, University of Auckland, Auckland, New Zealand.
Laboratory of Neuro Imaging, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

Fabio Macciardi (F)

Department of Psychiatry and Human Behavior, University of California, Irvine, Irvine, CA, USA.

Scott Mackey (S)

Department of Psychiatry, University of Vermont, Burlington, VT, USA.

Andrew R Mayer (AR)

Mind Research Network, Albuquerque, NM, USA.

Carrie R McDonald (CR)

Center for Multimodal Imaging and Genetics, University of California, San Diego, La Jolla, CA, USA.
Psychiatry, San Diego, CA, USA.

Agnes B McMahon (AB)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
The Kavli Foundation, Los Angeles, CA, USA.

Sarah E Medland (SE)

Psychiatric Genetics, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Gemma Modinos (G)

Department of Neuroimaging, Institute of Psychology, Psychiatry and Neurosciences, King's College London, London, UK.
Department of Psychosis Studies, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.

Rajendra A Morey (RA)

Department of Psychiatry, Duke University School of Medicine, Durham, NC, USA.
Mental Illness Research Education and Clinical Center, Durham VA Medical Center, Durham, NC, USA.

Sven C Mueller (SC)

Experimental Clinical & Health Psychology, Ghent University, Ghent, Belgium.
Department of Personality, Psychological Assessment and Treatment, University of Deusto, Bilbao, Spain.

Pratik Mukherjee (P)

Radiology and Biomedical Imaging, San Francisco, CA, USA.

Leyla Namazova-Baranova (L)

Research and Scientific Institute of Pediatrics and Child Health, CCH RAS, Ministry of Science and Higher Education, Moscow, Russian Federation.
Department of Pediatrics, Russian National Research Medical University MoH RF, Moscow, Russian Federation.

Talia M Nir (TM)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Alexander Olsen (A)

Department of Psychology, Norwegian University of Science and Technology, Trondheim, Norway.
Department of Physical Medicine and Rehabilitation, St. Olavs Hospital, Trondheim University Hospital, Trondheim, Norway.

Peristera Paschou (P)

Biological Sciences, Purdue University, West Lafayette, IN, USA.

Daniel S Pine (DS)

National Institute of Mental Health Intramural Research Program, Bethesda, MD, USA.

Fabrizio Pizzagalli (F)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Miguel E Rentería (ME)

Department of Genetics and Computational Biology, QIMR Berghofer Medical Research Institute, Brisbane, QLD, Australia.

Jonathan D Rohrer (JD)

Department of Neurodegenerative Disease, UCL Queen Square Institute of Neurology, London, UK.

Philipp G Sämann (PG)

Max Planck Institute of Psychiatry, Munich, Germany.

Lianne Schmaal (L)

Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia.
Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia.

Gunter Schumann (G)

Centre for Population Neuroscience and Precision Medicine (PONS), MRC SGDP Centre, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK.
Department of Psychiatry and Psychotherapy, Charite, Humboldt University, Berlin, Germany.

Mark S Shiroishi (MS)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.
Department of Radiology, Keck School of Medicine of USC, University of Southern California, Los Angeles, CA, USA.

Sanjay M Sisodiya (SM)

Department of Clinical and Experimental Epilepsy, University College London, London, UK.
Chalfont Centre for Epilepsy, Chalfont St Peter, UK.

Dirk J A Smit (DJA)

Department of Psychiatry, Amsterdam UMC, University of Amsterdam, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Ida E Sønderby (IE)

Norwegian Centre for Mental Disorders Research (NORMENT), Division of Mental Health & Addiction, Institute of Clinical Medicine, University of Oslo, Oslo, Norway.
Division of Mental Health and Addiction, Oslo University Hospital, Oslo, Norway.
Department of Medical Genetics, Oslo University Hospital, Oslo, Norway.

Dan J Stein (DJ)

Department of Psychiatry & Neuroscience Institute, SA MRC Unit on Risk & Resilience in Mental Disorders, Cape Town, South Africa.

Jason L Stein (JL)

Department of Genetics & UNC Neuroscience Center, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.

Masoud Tahmasian (M)

Institute of Medical Science and Technology, Shahid Beheshti University, Tehran, I. R., Iran.

David F Tate (DF)

Department of Neurology, TBI and Concussion Center, Salt Lake City, UT, USA.
Missouri Institute of Mental Health, Berkeley, MO, USA.

Jessica A Turner (JA)

Psychology Department & Neuroscience Institute, Georgia State University, Atlanta, GA, USA.

Odile A van den Heuvel (OA)

Department of Anatomy & Neurosciences, Amsterdam UMC, Location VUmc, Amsterdam Neuroscience, Amsterdam, The Netherlands.
Department of Psychiatry, Amsterdam UMC, Location VUmc, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Nic J A van der Wee (NJA)

Department of Psychiatry, Leiden University Medical Center, Leiden, The Netherlands.
Leiden Institute for Brain and Cognition, Leiden, The Netherlands.

Ysbrand D van der Werf (YD)

Department of Anatomy & Neurosciences, Amsterdam UMC, Location VUmc, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Theo G M van Erp (TGM)

Clinical Translational Neuroscience Laboratory, Department of Psychiatry and Human Behavior, University of California Irvine, Irvine, CA, USA.
Center for the Neurobiology of Learning and Memory, University of California, Irvine, Irvine, CA, USA.

Neeltje E M van Haren (NEM)

Department of Psychiatry, UMC Brain Center, University Medical Center Utrecht, Utrecht University, Utrecht, The Netherlands.
Department of Child and Adolescent Psychiatry/Psychology, Erasmus Medical Centre, Rotterdam, The Netherlands.

Daan van Rooij (D)

Donders Centre for Cognitive Neuroimaging, Radboud University Medical Centre, Nijmegen, The Netherlands.

Laura S van Velzen (LS)

Orygen, The National Centre of Excellence in Youth Mental Health, Melbourne, VIC, Australia.
Centre for Youth Mental Health, The University of Melbourne, Melbourne, VIC, Australia.

Ilya M Veer (IM)

Division of Mind and Brain Research, Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Dick J Veltman (DJ)

Department of Psychiatry, Amsterdam UMC, Location VUmc, Amsterdam Neuroscience, Amsterdam, The Netherlands.

Julio E Villalon-Reina (JE)

Imaging Genetics Center, Mark and Mary Stevens Neuroimaging and Informatics Institute, Keck School of Medicine, University of Southern California, Marina del Rey, CA, USA.

Henrik Walter (H)

Division of Mind and Brain Research, Department of Psychiatry and Psychotherapy CCM, Charité - Universitätsmedizin Berlin, corporate member of Freie Universität Berlin, Humboldt-Universität zu Berlin, and Berlin Institute of Health, Berlin, Germany.

Christopher D Whelan (CD)

Molecular and Cellular Therapeutics, Royal College of Surgeons in Ireland, Dublin, Ireland.
Research and Early Development, Biogen Inc, Cambridge, MA, USA.

Elisabeth A Wilde (EA)

Department of Neurology, University of Utah, Salt Lake City, UT, USA.
VA Salt Lake City Healthcare System, Salt Lake City, UT, USA.
Department of Physical Medicine and Rehabilitation, Baylor College of Medicine, Houston, TX, USA.

Mojtaba Zarei (M)

Institute of Medical Science and Technology, Shahid Beheshti University, Tehran, I. R., Iran.

Vladimir Zelman (V)

Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.
Skolkovo Institute of Science and Technology, Moscow, Russian Federation.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH